Who is the largest CBD company?

The largest company with a CBD product based on market cap is Jazz Pharmaceuticals (NASDAQ:JAZZ).

Is CBD a good business to invest in?

The CBD industry could be a good investment choice if the regulations included in the 2018 farm bill are reinstated or if the FDA changes its policies to allow CBD in food supplements. For now, though, the industry's growth prospects could be somewhat limited.

What state buys the most CBD?

California is the biggest CBD market in the U.S.

How do regulations affect CBD stocks?

Federal and state regulations have significant impacts on CBD stocks, including:Laws and regulations regarding the THC (tetrahydrocannabinol) level allowed in the cannabis used in CBD products can change and vary from state to state.Individual states can limit access to their markets for CBD products.The quality and testing standards for CBD can vary from state to state, driving higher costs for CBD companies.Future FDA regulations related to CBD in food, beverages, and dietary products could greatly affect the growth potential for CBD stocks.

How are CBD stocks different from regular cannabis stocks?

Cannabis stocks are shares of publicly traded companies that grow, process, or market cannabis products or provide products and services to other companies in the cannabis industry. CBD stocks are shares of publicly traded companies that are involved in the processing and distribution of CBD or provide tools and services to other companies in the CBD industry. The main differences between cannabis and CBD stocks are the legal and regulatory restrictions that they face and their market access. Cannabis stocks are more heavily regulated than CBD stocks.

Should I invest in individual CBD companies or ETFs?

The answer to this question depends on your risk tolerance. Investing in individual CBD companies offers the potential for higher rewards, but it also involves greater risk than investing in an ETF that owns a basket of stocks.

Is CBD a growing industry?

Yes, the CBD market is projected to grow from around $20.3 billion in 2026 to $62.6 billion by 2030.

Best CBD Stocks for 2026 and How to Invest

Here's what you need to know about the top CBD stocks.

By Keith Speights – Updated Mar 18, 2026 at 4:31 PM EST | Fact-checked by Frank Bass

Key Points

After 2018 federal legalization, U.S. CBD market growth didn't meet investor expectations.
Recent regulatory changes by U.S. Congress may further impact the CBD industry in 2026.
Investors should consider these changes and company fundamentals when selecting CBD stocks.

Loading paragraph...

Ticker Information Table
Name and ticker	Current price	Market cap
Cresco Labs (OTC:CRLBF)	$0.90	$360.0 million
Green Thumb Industries (OTC:GTBIF)	$6.56	$1.6 billion
Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)	$190.94	$11.5 billion
Trulieve Cannabis (OTC:TCNNF)	$6.02	$1.2 billion

Data as of Apr 7, 2026. Showing 4 of 4 tickers.

Loading ticker_table...

Loading paragraph...

OTC: CRLBF

Cresco Labs

Today's Change

(-9.94%) $-0.10

Current Price

$0.90

Key Data Points

Market Cap

$360M

Day's Range

$0.89 - $1.01

52wk Range

$0.43 - $2.30

Volume

461K

Avg Vol

939K

Gross Margin

45.65%

Loading company_card...

Cresco Labs (CRLBF -9.94%) is an Illinois-based cannabis operator that markets recreational and medical cannabis products in eight states. The company is more than just a cannabis producer and retailer. Cresco also markets branded cannabis products containing CBD, including its Wonder gummies. It commands the leading market share in multiple markets of $1 billion or more.

Cresco has grown significantly through the years, both organically and through acquisitions, and it consistently generates solid free cash flow. The company also stands to benefit from tax changes related to the federal rescheduling of marijuana.

Perhaps the biggest knock against Cresco is that the company can't list its shares on a major U.S. stock exchange as long as marijuana remains illegal at the federal level. However, Cresco has proven that it can still attract investors through the U.S. over-the-counter (OTC) markets.

Loading paragraph...

Loading pitch...

2. Green Thumb Industries

Loading paragraph...

OTC: GTBIF

Green Thumb Industries

Today's Change

(-7.61%) $-0.54

Current Price

$6.56

Key Data Points

Market Cap

$1.6B

Day's Range

$6.56 - $7.11

52wk Range

$4.76 - $10.43

Volume

217K

Avg Vol

593K

Gross Margin

45.90%

Loading company_card...

Loading paragraph...

NASDAQ: JAZZ

Jazz Pharmaceuticals Plc

Today's Change

(2.19%) $4.09

Current Price

$190.94

Key Data Points

Market Cap

$12B

Day's Range

$185.47 - $191.40

52wk Range

$95.49 - $198.00

Volume

802K

Avg Vol

995K

Gross Margin

72.87%

Loading company_card...

You might be surprised to find a pharmaceutical stock listed among the top CBD stocks to consider. But Jazz Pharmaceuticals (JAZZ +2.19%) has a direct and important connection with CBD. In 2018, the company's Epidiolex became the first CBD product made from the cannabis plant to win FDA approval.

Jazz actually didn't own Epidiolex at that time. It acquired GW Pharmaceuticals, which developed the CBD drug to treat epileptic seizures, for $6.7 billion in 2021. Epidiolex is not too far from generating annual sales of $1 billion or more, as some analysts projected after it was first approved in the U.S. Sales continue to pick up, as the drug is now approved in more than 35 countries outside the U.S.

Jazz also has other growth drivers in its lineup. Sleep disorder drug Xywav is gaining momentum. The company also launched its biliary tract cancer drug Ziihera in December 2024, and its newest product, Modeyso, used to treat diffuse midline glioma, was granted FDA approval in August 2025.

4. Trulieve Cannabis

Loading paragraph...

OTC: TCNNF

Trulieve Cannabis

Today's Change

(-7.38%) $-0.48

Current Price

$6.02

Key Data Points

Market Cap

$1.2B

Day's Range

$6.00 - $6.63

52wk Range

$3.10 - $11.83

Volume

275K

Avg Vol

225K

Gross Margin

50.25%

Loading company_card...

Trulieve Cannabis (TCNNF -7.38%) is a Florida-based cannabis operator. It has retail dispensaries in nine states and cultivation and processing facilities in seven states. The company is especially dominant in its home state's medical cannabis market. Roughly 70% of Trulieve's retail locations are in Florida. Trulieve also has leading market positions in Arizona and Pennsylvania.

Like Cresco Labs and Green Thumb Industries, Trulieve generates most of its revenue from cannabis sales. However, it also markets CBD products, including tinctures.

Trulieve experienced a setback when Florida voters rejected a constitutional amendment in November 2024 that would have legalized recreational marijuana. The amendment required 60% approval to pass, but it received only around 56%.

However, supporters plan to continue pushing for the legalization of recreational marijuana. Trulieve could still have a major growth opportunity in its home state in the future.

Loading paragraph...

Loading pitch...

Investing in CBD stocks FAQ

Loading faq...

About the Author

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

TMFFishBiz

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Cresco Labs and Green Thumb Industries. The Motley Fool has a disclosure policy.

Best CBD Stocks for 2026 and How to Invest

Here's what you need to know about the top CBD stocks.

Key Points

Key Data Points

2. Green Thumb Industries

Key Data Points

Key Data Points

4. Trulieve Cannabis

Key Data Points

Related investing topics

Biotech vs. Pharma: What's the Difference?

Best Psychedelic Stocks to Buy in 2026

Best Biotech Stocks to Buy in 2026 and How to Invest in Them

Best Healthcare Stocks to Buy in 2026 and How to Invest in Them

Investing in CBD stocks FAQ

Who is the largest CBD company?

Who is the largest CBD company?

Is CBD a good business to invest in?

Is CBD a good business to invest in?

What state buys the most CBD?

What state buys the most CBD?

How do regulations affect CBD stocks?

How do regulations affect CBD stocks?

How are CBD stocks different from regular cannabis stocks?

How are CBD stocks different from regular cannabis stocks?

Should I invest in individual CBD companies or ETFs?

Should I invest in individual CBD companies or ETFs?

Is CBD a growing industry?

Is CBD a growing industry?

About the Author

Read Next

Stocks Mentioned

Premium Investing Services

Investing in CBD stocks FAQ

Who is the largest CBD company?

Who is the largest CBD company?

Is CBD a good business to invest in?

Is CBD a good business to invest in?

What state buys the most CBD?

What state buys the most CBD?

How do regulations affect CBD stocks?

How do regulations affect CBD stocks?

How are CBD stocks different from regular cannabis stocks?

How are CBD stocks different from regular cannabis stocks?

Should I invest in individual CBD companies or ETFs?

Should I invest in individual CBD companies or ETFs?

Is CBD a growing industry?

Is CBD a growing industry?

Top CDB stocks for 2026

Biotech vs. Pharma: What's the Difference?

Best Psychedelic Stocks to Buy in 2026

Best Biotech Stocks to Buy in 2026 and How to Invest in Them

Best Healthcare Stocks to Buy in 2026 and How to Invest in Them

Key Data Points

1. Cresco Labs

2. Green Thumb Industries

What to consider before choosing a CBD stock

Benefits and risks of investing in CBD stocks

How to invest in CBD stocks

Tips for successful CBD stock investing

Related investing topics

FAQ

Key Data Points

Key Data Points

Key Data Points

3. Jazz Pharmaceuticals

4. Trulieve Cannabis